Coya Therapeutics
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $10M
Investors
- 1
About Coya Therapeutics
Founded in 2020 and based in Texas, US, Coya Therapeutics, Inc. is a clinical-stage biotechnology company developing approaches to utilizing adaptive regulatory T cells (Tregs) to target disease. The company was founded by its CEO, Howard Berman. In December 2023, Coya Therapeutics, Inc. The company is listed on Nasdaq under the ticker COYA. The company specializes in the development of therapies aimed at enhancing regulatory T cell (Treg) function. These therapies target a range of conditions, including neurodegenerative, autoimmune, and metabolic diseases. Coya’s approach focuses on multiple Treg therapeutic modalities, leveraging data, particularly in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s disease. Coya Therapeutics' product pipeline includes COYA 302 and COYA 301, which are Treg-enhancing biologics intended to bolster the body's regulatory T cells to combat disease; COYA 201, which comprises allogeneic Treg-derived exosomes, which are small vesicles that carry therapeutic benefits for neurodegenerative and autoimmune conditions; and COYA 101, which is an autologous Treg cell therapy where a patient's own cells are used to enhance their immune system's regulatory capabilities.
Who invested in Coya Therapeutics
1 investor across 1 round
See all investors in Coya Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 22, 2020
Amount
$10M
Investors
Questions about Coya Therapeutics
Who invested in Coya Therapeutics?
Coya Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Coya Therapeutics raised?
Coya Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Coya Therapeutics last raise money?
Coya Therapeutics's most recent round on record is a Series A, in Dec 2020.
What does Coya Therapeutics do?
Founded in 2020 and based in Texas, US, Coya Therapeutics, Inc.
Where is Coya Therapeutics headquartered?
Coya Therapeutics is headquartered in Houston, US.
Which VCs invest in companies like Coya Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Coya Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Coya Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.